Topic:

Partnering

Latest Headlines

Latest Headlines

Bellicum puts up $50M for Ariad's R&D tech

Bellicum Pharmaceuticals has switched up its deal with Ariad Pharmaceuticals, agreeing to hand over $50 million for a no-strings-attached license to some cell-signaling technology.

Unilife inks 15-year deal with Sanofi for wearable injectors

Unilife, the injectable technology provider, has inked a deal with Sanofi to be the French drugmaker's sole provider of cartridge-based wearable injectors for the next 15 years.

Baxter backs Rockwell with a $45M hemodialysis deal

Kidney drug developer Rockwell Medical picked up a big co-sign from a leader in the space, signing a deal with Baxter International that will help pay the way for its late-stage iron-delivery treatment.

Boehringer pilots inhalers with sensors to encourage patient adherence

Boehringer Ingelheim envisions some day selling day a smart inhaler that can tell patients when its medication is running low and remind them if they missed a prescheduled dose. 

Microsoft, Aerocrine partner to send asthma device data to the cloud

Aerocrine has partnered with Microsoft in a pilot project to send data from nitric oxide monitoring devices to the cloud for analysis.

Post-IPO Ergomed keeps rolling with its risk-sharing partnerships

U.K. drug development outfit Ergomed has come out the other end of its London IPO, touting a range of R&D partnerships that give it a chance to share the rewards of its clients' work.

Catalent partners up with Cingulate on two ADHD drugs

The recently IPO'd Catalent has signed a deal with biotech Cingulate Therapeutics to help develop a duo of candidates for ADHD, tapping its expertise in crafting controlled-release tablets.

Evotec lends its R&D might to the multiple sclerosis cause

Germany's Evotec has joined a trio of research projects focused on multiple sclerosis, contributing its developmental know-how to some early-stage R&D.

Pharmacyclics, Servier call it quits on a cancer drug

Pharmacyclics and Servier are quietly walking away from a 5-year collaboration on a new cancer treatment, leaving the former company to go it alone on mid-stage oral drug with an uncertain future.

HealthKit pulled from iPhone 6 after update crashes customers' phones

Apple's HealthKit data-sharing platform for mobile health apps has been pulled from the iPhone 6's operating system after an upgrade to iOS 8 disrupted cellular service, resulting in a bucketful of delayed app launches or upgrades, to the benefit of competitors.